Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem™ into clinic ...Middle East

LUND, Sweden, July 12, 2021 /PRNewswire/ -- Amniotics AB (publ) ("Amniotics" or the "Company"), a stem cell therapy company has raised SEK60 million through its recent listing on Nasdaq First North Growth Market. The offering was fully subscribed and attracted widespread interest from...

Hence then, the article about stem cell therapy company amniotics raises sek 60 million before deduction of transaction costs in first north ipo to advance lead candidate pulmostem into clinic was published today ( Monday 12/07/2021 - 10:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem™ into clinic )

Also on site :

• Worldline and EcoFlow announce strategic partnership to power seamless global payments
• Booths Filling Fast: Industrial Technology World Asia Vietnam 2026 Targets ASEAN's Manufacturing Boom
• SAP und Cyberwave setzen vollständig autonome, KI-gestützte Roboter in einem realen SAP-Logistiklager ein